We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16B
AUM Growth
-$1.4B
Cap. Flow
-$442M
Cap. Flow %
-2.77%
Top 10 Hldgs %
29.19%
Holding
720
New
51
Increased
199
Reduced
358
Closed
49

Top Sells

Rank Stock Value
1
ALTR
Altair Engineering Inc
ALTR
+$67M
2
UNH icon
UnitedHealth
UNH
+$44.7M
3
APH icon
Amphenol
APH
+$43.9M
4
BDX icon
Becton Dickinson
BDX
+$36.4M
5
LLY icon
Eli Lilly
LLY
+$36.1M

Sector Composition

Rank Sector Weight
1 Technology 31.51%
2 Healthcare 25.4%
3 Financials 11.6%
4 Consumer Discretionary 7.99%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$996M 6.24%
2,651,907
-15,281
-0.6% -$6.23M
NVDA icon
2
NVIDIA
NVDA
$5.14T
$796M 4.99%
7,345,760
+284,702
+4% +$36.1M
AAPL icon
3
Apple
AAPL
$4.79T
$757M 4.74%
3,408,616
-139,280
-4% -$32.3M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.17T
$412M 2.58%
2,666,581
-97,812
-4% -$17.7M
LLY icon
5
Eli Lilly
LLY
$1.04T
$397M 2.49%
480,854
-43,358
-8% -$36.1M
AMZN icon
6
Amazon
AMZN
$2.63T
$394M 2.47%
2,072,942
+49,171
+2% +$10.7M
MA icon
7
Mastercard
MA
$470B
$256M 1.6%
466,514
-49,080
-10% -$26.7M
PG icon
8
Procter & Gamble
PG
$347B
$224M 1.4%
1,312,540
+54,871
+4% +$9.19M
META icon
9
Meta Platforms (Facebook)
META
$1.59T
$218M 1.37%
378,729
+187,309
+98% +$121M
TMO icon
10
Thermo Fisher Scientific
TMO
$196B
$210M 1.32%
422,354
+14,864
+4% +$8.05M
AVGO icon
11
Broadcom
AVGO
$1.89T
$197M 1.23%
1,175,811
+44,274
+4% +$9.37M
CRM icon
12
Salesforce
CRM
$133B
$194M 1.22%
724,227
+60,348
+9% +$18.8M
MRK icon
13
Merck
MRK
$315B
$193M 1.21%
2,148,488
-68,935
-3% -$6.44M
JPM icon
14
JPMorgan Chase
JPM
$926B
$187M 1.17%
764,309
+792
+0.1% +$202K
V icon
15
Visa
V
$672B
$187M 1.17%
534,029
-73,119
-12% -$24.7M
WM icon
16
Waste Management
WM
$94.9B
$180M 1.12%
775,429
-140,844
-15% -$31.2M
GILD icon
17
Gilead Sciences
GILD
$162B
$176M 1.1%
1,574,444
-148,872
-9% -$15.4M
ISRG icon
18
Intuitive Surgical
ISRG
$121B
$173M 1.09%
349,931
+102,304
+41% +$56.6M
AMGN icon
19
Amgen
AMGN
$198B
$158M 0.99%
506,203
-111,322
-18% -$32.9M
TSM icon
20
TSMC
TSM
$2.18T
$153M 0.96%
922,352
+54,240
+6% +$10.5M
UNH icon
21
UnitedHealth
UNH
$392B
$153M 0.96%
291,758
-87,423
-23% -$44.7M
GOOG icon
22
Alphabet (Google) Class C
GOOG
$4.17T
$143M 0.9%
914,789
-26,283
-3% -$4.81M
HD icon
23
Home Depot
HD
$330B
$137M 0.86%
372,689
+9,002
+2% +$3.51M
REGN icon
24
Regeneron Pharmaceuticals
REGN
$68.3B
$136M 0.85%
214,941
-46,557
-18% -$32M
PANW icon
25
Palo Alto Networks
PANW
$273B
$136M 0.85%
795,693
+27,797
+4% +$5.14M

Similar funds

Candriam SCA's Q1 2025 Portfolio in Review

As of Q1 2025, Candriam SCA held 720 positions worth $16B, down 8.1% from $17.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Candriam SCA's Q1 2025 filing shows 51 new, 199 increased, 358 reduced and 49 closed positions. Its largest new stake was BeOne Medicines Ltd: 285,893 shares worth $77.8M. The largest sale was Altair Engineering Inc, an estimated $67M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2025 buy was BeOne Medicines Ltd: 285,893 shares worth $77.8M.
  • Candriam SCA added most to Meta Platforms (Facebook) in Q1 2025, an estimated $121M increase.
  • Candriam SCA's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $44.7M.
  • Candriam SCA fully exited Altair Engineering Inc in Q1 2025, selling an estimated $67M.
  • Candriam SCA's ten largest holdings make up 29% of its $16B portfolio in Q1 2025.
  • Candriam SCA opened 51 new positions and closed 49 in Q1 2025.
  • Candriam SCA's portfolio value fell 8.1% quarter-over-quarter to $16B.

Based on Candriam SCA's 13F filing for Q1 2025, filed 14 May 2025.